{"product_id":"tirzepatide-research-reference-material","title":"Tirzepatide RESEARCH REFERENCE MATERIAL","description":"\u003cp\u003e\u003cstrong\u003eBATCH NR: NBLTR107261101\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQUALITY TESTING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e✓ PURITY\u003cbr\u003e✓ WEIGHT\u003cbr\u003e✓ IDENTITY CONFIRMED (MS + FTIR)\u003c\/p\u003e\n\u003cp\u003e\u003ca rel=\"noopener\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/1058\/8363\/1948\/files\/LYO-0382_Tirzepatide.pdf?v=1784823463\" target=\"_blank\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/a\u003e\u003cstrong\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/1058\/8363\/1948\/files\/LYO-0383_BPC-157.pdf?v=1784823463\" rel=\"noopener\" target=\"_blank\"\u003eView Certificate of Analysis for this\u003c\/a\u003e batch →\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTIRZEPATIDE — RESEARCH REFERENCE MATERIAL\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cmeta charset=\"UTF-8\"\u003e\u003cstrong\u003eTest Results\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eDate Tested: 23.07.2026\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003ePurity (HPLC): 99.3%\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eNet Weight: 9.94 mg\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eMolecular Identity (MS): 4813 Da — confirmed\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eSpectral Identity (FTIR): Confirmed match to reference standard\u003c\/strong\u003e\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTirzepatide is a synthetic 39-amino-acid peptide compound studied in vitro as a dual agonist at GLP-1 and GIP receptor sites. It is supplied strictly as a laboratory reference standard for use in qualified research settings.\u003c\/p\u003e\n\u003cp\u003eThis product is intended solely for in vitro laboratory research and is not formulated, labeled, or approved for human or animal administration.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eMolecular Characteristics\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eProperty\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeptide Class\u003c\/td\u003e\n\u003ctd\u003eDual GLP-1R \/ GIPR ligand (synthetic)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSequence Length\u003c\/td\u003e\n\u003ctd\u003e39 amino acids\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolecular Weight\u003c\/td\u003e\n\u003ctd\u003e~4,813 Da\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStructural Modification\u003c\/td\u003e\n\u003ctd\u003eFatty acid chain (albumin-binding moiety)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eForm Supplied\u003c\/td\u003e\n\u003ctd\u003eLyophilized powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAS \/ Purity Method\u003c\/td\u003e\n\u003ctd\u003eHPLC-verified, batch-specific COA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eReceptor Pharmacology (In Vitro Research Context)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePublished in vitro and preclinical literature describes tirzepatide as engaging two receptor systems:\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eGLP-1 Receptor Binding\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStudied for glucose-dependent modulation of insulin secretion in cell-based assays\u003c\/li\u003e\n\u003cli\u003eInvestigated for effects on glucagon signaling in experimental models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eGIP Receptor Binding\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStudied for receptor-level insulin secretion pathways\u003c\/li\u003e\n\u003cli\u003eInvestigated in preclinical models of lipid and energy metabolism signaling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003eDual Receptor Engagement\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eA subject of ongoing preclinical structure-activity research into combined incretin receptor pharmacology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eHandling \u0026amp; Storage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLyophilized Form Only:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStore at –20°C\u003c\/li\u003e\n\u003cli\u003eProtect from light and moisture\u003c\/li\u003e\n\u003cli\u003eAvoid repeated freeze-thaw cycles\u003c\/li\u003e\n\u003cli\u003eHandle under standard sterile laboratory technique\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis product is shipped and stored exclusively as a lyophilized powder for laboratory use. No reconstitution or administration guidance is provided, as this material is not intended for use outside a controlled research setting.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Literature Keywords\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eGLP-1 \/ GIP dual receptor agonist pharmacology\u003c\/li\u003e\n\u003cli\u003eIncretin receptor binding assays\u003c\/li\u003e\n\u003cli\u003eAlbumin-binding peptide pharmacokinetic modeling\u003c\/li\u003e\n\u003cli\u003eStructure-activity relationship, incretin peptides\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Use Disclaimer\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis product is intended exclusively for laboratory research by qualified professionals.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNot for human or veterinary use\u003c\/li\u003e\n\u003cli\u003eNot for diagnostic or therapeutic use\u003c\/li\u003e\n\u003cli\u003eNot a drug, supplement, or cosmetic\u003c\/li\u003e\n\u003cli\u003eNot for internal, topical, or any form of consumption\u003c\/li\u003e\n\u003cli\u003eSold only to buyers who confirm appropriate research qualifications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBy purchasing this product, the buyer confirms it will be used solely for in vitro laboratory research in accordance with applicable local, national, and international regulations.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e\u003cstrong\u003eScientific References\u003c\/strong\u003e Peer-reviewed literature on GLP-1\/GIP receptor pharmacology, available via PubMed.\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"NORDBIOLAB operated by Leiterin OÜ","offers":[{"title":"10 MG","offer_id":58193704747340,"sku":null,"price":129.0,"currency_code":"EUR","in_stock":true},{"title":"30 MG","offer_id":58193969119564,"sku":null,"price":279.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1058\/8363\/1948\/files\/nordbiolab-tirzepatide-holographic-vial.png?v=1782719270","url":"https:\/\/nordbiolab.com\/products\/tirzepatide-research-reference-material","provider":"NORDBIOLAB","version":"1.0","type":"link"}